Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
1.230
-0.220 (-15.17%)
At close: Oct 15, 2026, 4:00 PM EDT
1.191
-0.039 (-3.17%)
After-hours: Oct 15, 2026, 7:59 PM EDT
Valion Bio Market Cap
Valion Bio has a market cap or net worth of $1.09 million as of October 15, 2026. It is the 49,272nd most valuable company in the world and the 6,704th biggest in the United States. Its market cap has decreased by 76.96% in one year.
Market Cap
1.09M
Enterprise Value
16.39M
1-Year Change
-76.96%
Global Rank
Country Rank
#6,704 United States
Category
ChartMarket Cap Chart
Since November 11, 2021, Valion Bio's market cap has decreased from $48.09M to $1.09M, a decrease of -97.73%. That is a compound annual growth rate of -53.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 1.09M | -70.19% |
| Dec 31, 2025 | 3.66M | 11.74% |
| Dec 31, 2024 | 3.28M | 24.22% |
| Dec 29, 2023 | 2.64M | -57.26% |
| Dec 30, 2022 | 6.17M | -83.58% |
| Dec 31, 2021 | 37.60M | -21.81% |
| Nov 11, 2021 | 48.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genprex | 2.06M |
| BioRestorative Therapies | 2.03M |
| Oragenics | 2.02M |
| Silo Pharma | 1.94M |
| Lakewood-Amedex Biotherapeutics | 1.64M |
| Artelo Biosciences | 1.63M |
| Virax Biolabs Group | 1.39M |
| Curis | 1.29M |